| Balance Sheets | 2025-07-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 3,957,752 | |||
| Marketable securities | 6,767,282 | |||
| Accounts receivable | 2,015,529 | |||
| Prepaids and other assets | 415,093 | |||
| Total current assets | 13,155,656 | |||
| Property and equipment, net | 131,526 | |||
| Operating lease right-of-use | 72,747 | |||
| Other assets | 225,649 | |||
| Total assets | 13,585,578 | |||
| Current operating lease liabilities | 71,362 | |||
| Accounts payable and accrued expenses | 874,379 | |||
| Current portion of us tcja transition tax and income taxes payable | 713,153 | |||
| Total current liabilities | 1,658,894 | |||
| Us tcja transition tax payable | 0 | |||
| Long-term operating lease liabilities | 0 | |||
| Total liabilities | 1,658,894 | |||
| Common stock, 0.0001 par value authorized 50,000,000 shares 23,519,672 and 23,519,672 shares issued, and 22,920,442 and 22,958,143 shares outstanding at july 31, 2025 and october 31, 2024, respectively | 2,352 | |||
| Additional paid-in capital | 1,675,148 | |||
| Retained earnings | 10,533,691 | |||
| Accumulated other comprehensive income | 285,577 | |||
| Treasury stock, at cost 599,230 and 561,529 common shares held at july 31, 2025 and october 31, 2024, respectively | 570,084 | |||
| Total stockholders' equity | 11,926,684 | |||
| Total liabilities and stockholders' equity | 13,585,578 | |||
Pharma-Bio Serv, Inc. (PBSV)
Pharma-Bio Serv, Inc. (PBSV)